BNR Stock Price Chart
BNR Earnings
Burning Rock Biotech Ltd
$11.75
9.35%
$1
At close: Jul 28, 16:00:00 GMT-4
$11.76
0.08%
$0
Post-market: Jul 28, 20:00:00 GMT-4
Back
Burning Rock Biotech Ltd (BNR) Earnings
Latest Earnings Results: Q3 '22
Reported: 2022-11-15
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did BNR's recent EPS compare to expectations?
How did Burning Rock Biotech Ltd BNR's revenue perform in the last quarter?
What is the revenue estimate for Burning Rock Biotech Ltd?
What's the earning quality score for Burning Rock Biotech Ltd?
When does Burning Rock Biotech Ltd report earnings?
What are Burning Rock Biotech Ltd's expected earnings?
Did Burning Rock Biotech Ltd beat earnings expectations?
Key Stats
Prev.Close
$10.74
Open
$11.15
Day's Range
$10.88 - $12.09
52 week range
$4.46 - $41.72
Volume
39.9K
Avg.Volume
27.3K
Dividend yield
--
EPS (TTM)
-0.56
Market Cap
$124.0M
What is BNR?
Burning Rock Biotech Ltd. engages in the investment of medical fields. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
